Rameswari Chilamakuri

7PUBLICATIONS
4CO-AUTHORS
Molecular targetsPredictive and prognostic markersMedical molecular engineering of nucleic acids and proteinsNeurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 29, 2025
Direct Targeting of CXCR2 Receptor Inhibits Neuroblastoma Growth: An In Vitro Assessment.

Rameswari Chilamakuri, Deepika Godugu, Saurabh Agarwal

|Oct 16, 2025
Striking at Survivin: YM-155 Inhibits High-Risk Neuroblastoma Growth and Enhances Chemosensitivity.

Danielle C Rouse, Rameswari Chilamakuri, Saurabh Agarwal

|Oct 26, 2024
Repurposing of c-MET Inhibitor Tivantinib Inhibits Pediatric Neuroblastoma Cellular Growth.

Rameswari Chilamakuri, Saurabh Agarwal

|Oct 14, 2022
Exploring Amodiaquine's Repurposing Potential in Breast Cancer Treatment-Assessment of In-Vitro Efficacy & Mechanism of Action.

Vineela Parvathaneni, Rameswari Chilamakuri, Nishant S Kulkarni

|Sep 22, 2022
Direct Targeting of the Raf-MEK-ERK Signaling Cascade Inhibits Neuroblastoma Growth.

Rameswari Chilamakuri, Saurabh Agarwal

|May 28, 2022
Inhibition of Polo-like Kinase 1 by HMN-214 Blocks Cell Cycle Progression and Inhibits Neuroblastoma Growth.

Rameswari Chilamakuri, Danielle Crystal Rouse, Saurabh Agarwal

Pageof 2

Frequent Collaborators

7 joint publications

Saurabh Agarwal

1 joint publications

Nabeela F Baig

1 joint publications

Vivek Gupta

1 joint publications

Danielle C Rouse